227 related articles for article (PubMed ID: 15291996)
21. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
Sliwińska M; Wojtacki J; Sliwiński W
Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
[TBL] [Abstract][Full Text] [Related]
22. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients.
Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V;
Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen and endometrial pathologies: a prospective study.
Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
[TBL] [Abstract][Full Text] [Related]
25. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Boccardo F; Rubagotti A; Puntoni M; Guglielmini P; Amoroso D; Fini A; Paladini G; Mesiti M; Romeo D; Rinaldini M; Scali S; Porpiglia M; Benedetto C; Restuccia N; Buzzi F; Franchi R; Massidda B; Distante V; Amadori D; Sismondi P
J Clin Oncol; 2005 Aug; 23(22):5138-47. PubMed ID: 16009955
[TBL] [Abstract][Full Text] [Related]
26. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
27. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
[TBL] [Abstract][Full Text] [Related]
28. A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.
Olson SH; Finstad CL; Harlap S; Kurian L; Saigo PE; Barakat RR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):815-7. PubMed ID: 9332764
[TBL] [Abstract][Full Text] [Related]
29. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker.
Powell MA; Mutch DG; Rader JS; Herzog TJ; Huang TH; Goodfellow PJ
Cancer; 2002 Jun; 94(11):2941-52. PubMed ID: 12115383
[TBL] [Abstract][Full Text] [Related]
30. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
31. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
32. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
33. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
34. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM
Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844
[TBL] [Abstract][Full Text] [Related]
35. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
36. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
37. A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial carcinomas.
Ramondetta LM; Palazzo JP; Dunton CJ; Kovatich AJ; Carlson JA
Anticancer Res; 1998; 18(6B):4661-5. PubMed ID: 9891537
[TBL] [Abstract][Full Text] [Related]
38. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
39. Endometrial cancer patients and tibolone: a matched case-control study.
Lee KB; Lee JM; Lee JK; Cho CH
Maturitas; 2006 Oct; 55(3):264-9. PubMed ID: 16678984
[TBL] [Abstract][Full Text] [Related]
40. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
